1. Home
  2. MATV vs DCTH Comparison

MATV vs DCTH Comparison

Compare MATV & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATV
  • DCTH
  • Stock Information
  • Founded
  • MATV 1995
  • DCTH 1988
  • Country
  • MATV United States
  • DCTH United States
  • Employees
  • MATV N/A
  • DCTH N/A
  • Industry
  • MATV Paper
  • DCTH Medical/Dental Instruments
  • Sector
  • MATV Basic Materials
  • DCTH Health Care
  • Exchange
  • MATV Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • MATV 361.1M
  • DCTH 394.9M
  • IPO Year
  • MATV 1995
  • DCTH N/A
  • Fundamental
  • Price
  • MATV $7.56
  • DCTH $11.41
  • Analyst Decision
  • MATV Strong Buy
  • DCTH Strong Buy
  • Analyst Count
  • MATV 1
  • DCTH 4
  • Target Price
  • MATV $10.00
  • DCTH $24.00
  • AVG Volume (30 Days)
  • MATV 594.3K
  • DCTH 962.0K
  • Earning Date
  • MATV 08-06-2025
  • DCTH 08-04-2025
  • Dividend Yield
  • MATV 5.28%
  • DCTH N/A
  • EPS Growth
  • MATV N/A
  • DCTH N/A
  • EPS
  • MATV N/A
  • DCTH N/A
  • Revenue
  • MATV $1,965,700,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • MATV $3.07
  • DCTH $162.10
  • Revenue Next Year
  • MATV $2.30
  • DCTH $32.97
  • P/E Ratio
  • MATV N/A
  • DCTH N/A
  • Revenue Growth
  • MATV N/A
  • DCTH 1068.87
  • 52 Week Low
  • MATV $4.34
  • DCTH $7.17
  • 52 Week High
  • MATV $19.96
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • MATV 58.86
  • DCTH 37.66
  • Support Level
  • MATV $7.19
  • DCTH $10.92
  • Resistance Level
  • MATV $7.87
  • DCTH $11.64
  • Average True Range (ATR)
  • MATV 0.29
  • DCTH 0.57
  • MACD
  • MATV -0.02
  • DCTH 0.06
  • Stochastic Oscillator
  • MATV 62.50
  • DCTH 27.22

About MATV Mativ Holdings Inc.

Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: